Mu Yifei, executive director of Tencent Investment: It is time to connect medical care

Mu Yifei, executive director of Tencent Investment: It is time to connect medical care

OFweek Medical Network January 22nd: In recent years, Tencent has a lot of layout in the field of Internet medical treatment. This time, Tencent and Pfizer, China Ping An and Junlian Capital jointly launched the "Medical Road Growth, Win-Win" Medical Partner Innovation The cooperation program contest shows that Tencent's medical layout has entered a new stage: to promote the development of the industry's ecology and promote more innovative enterprises that solve the Chinese medical pain points, and truly promote the development of China's medical industry.

In this competition, Tencent and Pfizer, Ping An, and Junlian Capital will invite China's best medical health innovation entrepreneurs to work together for a win-win situation, and strive to build China's best health care innovation and entrepreneurship ecosystem. The author also took the opportunity to interview Mu Yifei, executive director of Tencent Investment, to listen to his thoughts on medical innovation and how to use Tencent's superior resources to help entrepreneurs take off.

Mu Yifei, executive director of Tencent Investment: It is time to connect medical care

Investment strategy: respect the industry respect rules and follow the connector positioning

Cooperation with Tencent The other three sponsors of this medical partner innovation cooperation program competition are leading enterprises in the industry, such as China's financial giant China Ping An, the bidding company Junlian Capital, and the global pharmaceutical company boss Pfizer. As the only Internet company in the Quartet, what expectations does Tencent have for this cooperation?

Mu Yifei said that the Quartet has deep accumulation in their respective fields. This contest has given the Quartet a chance to contact and get close to each other. It is a very good learning and communication opportunity. And with this cooperation, the Quartet can dock their respective superior resources, provide the best help for entrepreneurs, and enable entrepreneurs to truly take off on the Quartet platform.

Mu Yifei said frankly that all aspects of China's medical system are relatively complete, but there are many places that are not perfect enough to cooperate well with each other. Tencent will continue to follow the connector positioning in the medical field, and is committed to connecting people, medical services, equipment, medical and health information through the Internet, adding “lubricants” to all links to enable the entire medical system to operate efficiently.

Mu Yifei particularly emphasized that the medical field is very professional. It is not an area that Tencent is good at. Tencent will abide by the consistent principle of respecting the industry and respecting the law, and maintain a learning attitude towards the industry, experts and entrepreneurs, so that experts and entrepreneurs can fully Play their professionalism. What Tencent wants to do is to come up with its own superior resources and help entrepreneurs develop rapidly.

For how to choose a specific entrepreneurial direction, will Tencent be happy to see entrepreneurs appear in a certain segment in a relatively concentrated manner? Mu Yifei made it clear that entrepreneurs are the most intelligent and professional group. Tencent will not set the direction of entrepreneurship in advance, but will maintain full openness, and everything will follow the entrepreneur's own choice.

Mu Yifei, executive director of Tencent Investment: It is time to connect medical care

Antibody Test Kit Of COVID-19

These test kits are performed on blood samples from infected persons became a useful tool in elucidating the links between several cases. These links would not have been made if viral particles were looked for via PCR methods. This is due to the fact that the patient's immune defence might be successful in eliminating the virus and hence removing any trace of where it came from. However, when specific antibodies are searched for in the same patient, they will be able to be detected because they stay within the blood for several years. Commercial immunoassay tests to detect COVID-19 include a dual ELISA test to be performed. This detects specific IgA and IgG against the virus in the blood of infected patients. There is also an automated fluorescent immunoassay system to measure quantitatively or semi-quantitatively the concentration of the targeted analyte, which can be the viral antigen or IgM/IgG.

antibody diagnostic kit, rapid antibody test kit, rapid antibody diagnosis,covid-19 antibody diagnosis, antibody detection kit

Shenzhen Uni-medica Technology Co.,Ltd , https://www.unimed-global.com